Amblyopia

Definition

Pathophysiology

• Ocular dominance plasticity: Cortical neurons normally receive input from both eyes. During the critical period, monocular deprivation shifts cortical representation heavily toward the non-deprived eye.
• Synaptic competition: Correction of the underlying cause can restore vision only if initiated during the critical period "when synapses in the visual cortex are still malleable."
• Brakes on plasticity in the adult cortex: Late-maturing inhibitory interneurons (parvalbumin-expressing GABAergic neurons) form perineuronal nets (PNNs) of chondroitin sulfate proteoglycans around their cell bodies. These PNNs limit adult synaptic plasticity. Degrading PNNs experimentally can reopen a window of plasticity - a target for future adult amblyopia therapy.
• Modulatory inputs matter: Noradrenergic (locus coeruleus) and cholinergic (basal forebrain) inputs are required for ocular dominance plasticity - merely having visual cortex activity is insufficient without behavioral engagement.

Classification

Diagnosis

• Critical: Poorer vision in one eye not fully corrected with refraction and not fully explained by an organic lesion. Central vision primarily affected; peripheral visual field usually normal.
• Crowding phenomenon: Individual letters are more easily read than a full line of letters. This occurs in normals too but is exaggerated in amblyopia; must be accounted for when testing preverbal children.
• Neutral-density filter effect: In reduced illumination, the visual acuity of an amblyopic eye drops far less than an organically diseased eye.
• Trace RAPD: Severe amblyopia may cause a subtle relative afferent pupillary defect (can be false-positive if light is directed off-axis, especially in strabismic patients).

Workup

1. History: Eye problems in childhood - misaligned eyes, patching, muscle surgery?
2. Ocular examination: Rule out organic cause for reduced vision (fundus exam mandatory before starting treatment).
3. Cover-uncover test: Evaluate eye alignment.
4. Cycloplegic refraction: Both eyes.
5. If acuity does not respond to treatment: consider electrophysiology or neuroimaging.

Treatment

Critical Period Considerations

• Sensitive period during which acuity can be improved: typically up to 7-8 years for strabismic amblyopia, and potentially into the teens for anisometropic amblyopia where good binocular function is present.
• The younger the patient, the more rapid the likely improvement - but also the greater the risk of inducing amblyopia in the normal eye (occlusion amblyopia).

For Patients Under 12 Years

• Prescribe full cycloplegic refraction (or reduce hyperopia symmetrically by ≥1.50 D in both eyes).
• Allow 6-12 weeks of refractive adaptation before moving to occlusion - refractive correction alone can improve vision substantially.

• Patch the better eye for 2-6 hours/day.
• Adhesive patches placed directly over the eye are most effective (patches over glasses allow peeking).
• Follow-up: 1 week per year of age (e.g., 3-year-old seen at 3 weeks).
• If no improvement after 6 months of effective occlusion, further patching is unlikely to help.
• Monitor VA in both eyes closely throughout treatment.

• Atropine 1% once daily blurs the better eye, encouraging use of the amblyopic eye.
• Equally effective as patching for mild-to-moderate amblyopia (20/100 or better).
• Advantages: cannot be thwarted by the child, fewer psychosocial issues than a visible patch.
• Weekend-only instillation may be adequate in some cases.
• Patch occlusion likely produces a quicker response; atropine is often reserved for poor patch compliance.

For Patients 12 Years and Older / Treatment Failures

• Treatment becomes progressively less effective with age due to reduced cortical plasticity.
• If treatment fails or the patient presents outside the treatment age range: prescribe protective glasses to safeguard the non-amblyopic eye.
• Any child who cannot achieve 20/40 must wear eye protection during sports (one-eyed athlete rule).

Emerging Therapies (research stage)

• Binocular treatments (dichoptic training, game-based therapy) are under active investigation - a 2024 systematic review (PMID: 39222269) found promising but not yet definitive results.
• Experimental approaches targeting perineuronal nets (PNN degradation via bacterial enzyme, ketamine, dark exposure, or retinal TTX block) can reopen cortical plasticity windows in animal models - not yet used in humans.

Prognosis and Follow-Up

• Poor compliance is the single greatest barrier to improvement. Communication and education at the outset are essential.
• Recurrence after treatment is possible; part-time patching may be needed to maintain vision gains.
• Long-term follow-up depends on patient age, prescribed patching intensity, and amblyopia severity.
• Bilateral amblyopia from untreated congenital cataracts carries a very poor prognosis if not addressed within the earliest months of life.